Our Hamburg location is now offering Spravato treatments.
Spravato (esketamine) treatment is a newer approach for adults with treatment-resistant depression (TRD) or major depressive disorder with acute suicidal ideation or behavior (MDSI). Spravato is a prescription nasal spray containing esketamine, a form of ketamine. It’s FDA-approved for use in conjunction with an oral antidepressant for patients with TRD who haven’t responded adequately to at least two other antidepressants. … Continue reading